Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 2
1998 4
1999 5
2000 13
2001 13
2002 14
2003 13
2004 9
2005 15
2006 13
2007 20
2008 19
2009 10
2010 8
2011 8
2012 7
2013 10
2014 5
2015 6
2016 2
2017 2
2018 1
2019 2
2021 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18214050

189 results

Results by year

Filters applied: . Clear all
Page 1
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Kosmidis P, Fountzilas G, Baka S, Samantas E, Dimopoulos AM, Gogas H, Skarlos D, Papacostas P, Boukovinas J, Bakogiannis Ch, Pantelakos P, Athanasiou H, Misailidou D, Tsekeris P, Pavlidis N. Kosmidis P, et al. Anticancer Res. 2007 Nov-Dec;27(6C):4391-5. Anticancer Res. 2007. PMID: 18214050 Free article. Clinical Trial.
Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS. Lee DH, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1037-44. doi: 10.1016/j.ijrobp.2005.04.034. Epub 2005 Jul 18. Int J Radiat Oncol Biol Phys. 2005. PMID: 16024178 Clinical Trial.
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L. Hirsh V, et al. J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92. J Thorac Oncol. 2007. PMID: 17909355 Free article. Clinical Trial.
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Bradley JD, et al. Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16. Lancet Oncol. 2015. PMID: 25601342 Free PMC article. Clinical Trial.
189 results